dc.contributorGEMpath Inc
dc.contributorJohnson & Johnson PRD
dc.contributorPrecclin Serv Europe
dc.contributorEttlin Consulting AG
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorIpsen Innovat
dc.contributorAccelera Srl
dc.contributorCovance Labs
dc.contributorAstraZeneca
dc.contributorYamamoto Green Village II 303
dc.contributorNovartis Inst BioMed Res
dc.contributorPfizer Inc
dc.contributorSeoul Natl Univ
dc.contributorRoyal Vet Coll
dc.contributorNagoya City Univ
dc.contributorAdvinus Therapeut Pvt Ltd
dc.contributorMerck Sharp & Dohme Ltd
dc.date.accessioned2014-05-20T13:37:28Z
dc.date.accessioned2022-10-05T13:51:14Z
dc.date.available2014-05-20T13:37:28Z
dc.date.available2022-10-05T13:51:14Z
dc.date.created2014-05-20T13:37:28Z
dc.date.issued2010-09-01
dc.identifierJournal of Toxicologic Pathology. Tokyo: Japanese Soc Toxicologic Pathology, v. 23, n. 3, p. 171-181, 2010.
dc.identifier0914-9198
dc.identifierhttp://hdl.handle.net/11449/12965
dc.identifier10.1293/tox.23.171
dc.identifierWOS:000282660200010
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3888665
dc.description.abstractThe International Federation of Societies of Toxicologic Pathologists (IFSTP) proposes a common global framework for training future toxicologic pathologists who will support regulatory-type nonclinical toxicology studies. Trainees optimally should undertake a scientific curriculum of at least 5 years at an accredited institution leading to a clinical degree (veterinary medicine or medicine). Trainees should then obtain 4 or more years of intensive pathology practice during a residency and/or on-the-job "apprenticeship," at least 2 years of which must be focused on regulatory-type toxicologic pathology topics. Possession of a recognized pathology qualification (i.e., certification) is highly recommended. A non-clinical pathway (e.g., a graduate degree in medical biology or pathology) may be possible if medically trained pathologists are scarce, but this option is not optimal. Regular, lifelong continuing education (peer review of nonclinical studies, professional meetings, reading, short courses) will be necessary to maintain and enhance one's understanding of current toxicologic pathology knowledge, skills, and tools. This framework should provide a rigorous yet flexible way to reliably train future toxicologic pathologists to generate, interpret, integrate, and communicate data in regulatory-type, nonclinical toxicology studies. (J Toxicol Pathol 2010; 23: 171-181)
dc.languageeng
dc.publisherJapanese Soc Toxicologic Pathology
dc.relationJournal of Toxicologic Pathology
dc.relation1.066
dc.relation0,453
dc.rightsAcesso aberto
dc.sourceWeb of Science
dc.subjecttoxicologic pathologists
dc.subjectproposed curriculum
dc.subjecttraining standards
dc.subjectregulatory-type non-clinical safety studies
dc.titleInternational Recommendations for Training Future Toxicologic Pathologists Participating in Regulatory-Type, Nonclinical Toxicity Studies
dc.typeArtigo


Este ítem pertenece a la siguiente institución